β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes

Clinical Orthopaedics and Related Research

Volumn 473, Issue 8, 2015, Pages 2495-2504

  Dai, Weiwei ^a,b   Zhang, HongLiang ^b,c   Zhong, Zhendong A ^b   Jiang, Li ^b,d   Chen, Haiyan ^b   Lay, Yu An Evan ^b   Kot, Alexander ^b   Ritchie, Robert O ^e   Lane, Nancy E ^b   Yao, Wei ^b  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d First Affil Hosp Dalian Med U   (China)

^e University of California Berkeley   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECDYSTERONE;

ANIMAL; BIOMECHANICS; BONE DENSITY; BONE DEVELOPMENT; BONE REMODELING; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; FEMUR; GROWTH, DEVELOPMENT AND AGING; LUMBAR VERTEBRA; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; ORCHIECTOMY; OVARIECTOMY; RADIOGRAPHY; SEX DIFFERENCE;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE DENSITY; BONE REMODELING; ECDYSTERONE; FEMALE; FEMUR; LUMBAR VERTEBRAE; MALE; MICE; ORCHIECTOMY; OSTEOGENESIS; OVARIECTOMY; SEX FACTORS; X-RAY MICROTOMOGRAPHY;

EID: 84934436308     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-015-4246-5     Document Type: Article

References (46)

1. Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O’Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007;282:27285–27297.
2. Bailey DA, McKay HA, Mirwald RL, Crocker PR, Faulkner RA. A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. J Bone Miner Res. 1999;14:1672–1679.
3. Bathori M. Phytoecdysteroids effects on mammalians, isolation and analysis. Mini Rev Med Chem. 2002;2:285–293.
4. Bathori M, Toth N, Hunyadi A, Marki A, Zador E. Phytoecdysteroids and anabolic-androgenic steroids—structure and effects on humans. Curr Med Chem. 2008;15:75–91.
5. Beck TJ, Ruff CB, Shaffer RA, Betsinger K, Trone DW, Brodine SK. Stress fracture in military recruits: gender differences in muscle and bone susceptibility factors. Bone. 2000;27:437–444.
6. Bonjour JP, Chevalley T, Ammann P, Slosman D, Rizzoli R. Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study. Lancet. 2001;358:1208–1212.
7. Boo KH, Lee D, Jeon GL, Ko SH, Cho SK, Kim JH, Park SP, Hong Q, Lee SH, Lee DS, Riu KZ. Distribution and biosynthesis of 20-hydroxyecdysone in plants of Achyranthes japonica Nakai. Biosci Biotechnol Biochem. 2010;74:2226–2231.
8. Cahlikova L, Macakova K, Chlebek J, Host’alkova A, Kulhankova A, Opletal L. Ecdysterone and its activity on some degenerative diseases. Nat Prod Commun. 2011;6:707–718.
9. Cheng DM, Kutzler LW, Boler DD, Drnevich J, Killefer J, Lila MA. Continuous infusion of 20-hydroxyecdysone increased mass of triceps brachii in C57BL/6 mice. Phytother Res. 2013;27:107–111.
10. Chokalingam K, Roforth MM, Nicks KM, McGregor U, Fraser D, Khosla S, Monroe DG. Examination of ERalpha signaling pathways in bone of mutant mouse models reveals the importance of ERE-dependent signaling. Endocrinology. 2012;153:5325–5333.
11. Courteix D, Jaffre C, Lespessailles E, Benhamou L. Cumulative effects of calcium supplementation and physical activity on bone accretion in premenarchal children: a double-blind randomised placebo-controlled trial. Int J Sports Med. 2005;26:332–338.
12. Dai W, Jiang L, Lay YA, Chen H, Jin G, Zhang H, Kot A, Ritchie RO, Lane NE, Yao W. Prevention of glucocorticoid induced bone changes with beta-ecdysone. Bone. 2015;74C:48–57.
13. Deasy BM, Lu A, Tebbets JC, Feduska JM, Schugar RC, Pollett JB, Sun B, Urish KL, Gharaibeh BM, Cao B, Rubin RT, Huard J. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol. 2007;177:73–86.
14. Dinan L. The Karlson Lecture. Phytoecdysteroids: what use are they? Arch Insect Biochem Physiol. 2009;72:126–141.
15. Dinan L, Lafont R. Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals. J Endocrinol. 2006;191:1–8.
16. Duan Y, Turner CH, Kim BT, Seeman E. Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss. J Bone Miner Res. 2001;16:2267–2275.
17. Esposito D, Komarnytsky S, Shapses S, Raskin I. Anabolic effect of plant brassinosteroid. FASEB J. 2011;25:3708–3719.
18. Gorelick-Feldman J, MacLean D, Ilic N, Poulev A, Lila MA, Cheng D, Raskin I. Phytoecdysteroids increase protein synthesis in skeletal muscle cells. J Agr Food Chem. 2008;56:3532–3537.
19. Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med. 2012;18:456–462.
20. Hong L, Sultana H, Paulius K, Zhang G. Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol. 2009;114:180–185.
21. Johansson AG, Engstrom BE, Ljunghall S, Karlsson FA, Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab. 1999;84:2002–2007.
22. Johnston CC Jr, Slemenda CW. Determinants of peak bone mass. Osteoporos Int. 1993;3(Suppl 1):54–55.
23. Jones G, Dwyer T. Bone mass in prepubertal children: gender differences and the role of physical activity and sunlight exposure. J Clin Endocrinol Metab. 1998;83:4274–4279.
24. Kapur P, Wuttke W, Jarry H, Seidlova-Wuttke D. Beneficial effects of beta-Ecdysone on the joint, epiphyseal cartilage tissue and trabecular bone in ovariectomized rats. Phytomedicine. 2010;17:350–355.
25. Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res. 2006;21:466–476.
26. Liao DJ, Dickson RB. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol. 2002;80:175–189.
27. Manolagas SC, O’Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9:699–712.
28. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O’Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310:1353–1368.
29. Matkovic V, Goel PK, Badenhop-Stevens NE, Landoll JD, Li B, Ilich JZ, Skugor M, Nagode LA, Mobley SL, Ha EJ, Hangartner TN, Clairmont A. Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial. Am J Clin Nutr. 2005;81:175–188.
30. Matsumoto T, Kubo S, Meszaros LB, Corsi KA, Cooper GM, Li G, Usas A, Osawa A, Fu FH, Huard J. The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum. 2008;58:3809–3819.
31. Orwoll ES, Belknap JK, Klein RF. Gender specificity in the genetic determinants of peak bone mass. J Bone Miner Res. 2001;16:1962–1971.
32. Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006;20:2492–2506.
33. Roehm E. A reappraisal of women’s health initiative estrogen-alone trial: long-term outcomes in women 50–59 years of age. Obstet Gynecol Int. 2015;2015:713295.
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.
35. Seidlova-Wuttke D, Christel D, Kapur P, Nguyen BT, Jarry H, Wuttke W. Beta-ecdysone has bone protective but no estrogenic effects in ovariectomized rats. Phytomedicine. 2010;17:884–889.
36. Truman JW. Hormonal control of insect ecdysis: endocrine cascades for coordinating behavior with physiology. Vitam Horm. 2005;73:1–30.
37. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone. 1993;14:595–608.
38. Wang Y, Sakata T, Elalieh HZ, Munson SJ, Burghardt A, Majumdar S, Halloran BP, Bikle DD. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I. J Endocrinol. 2006;189:279–287.
39. Ward KA, Roberts SA, Adams JE, Lanham-New S, Mughal MZ. Calcium supplementation and weight bearing physical activity—do they have a combined effect on the bone density of pre-pubertal children? Bone. 2007;41:496–504.
40. Weinstein RS, Jia D, Powers CC, Stewart SA, Jilka RL, Parfitt AM, Manolagas SC. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. Endocrinology. 2004;145:1980–1987.
41. Weinstein RS, Jilka RL, Almeida M, Roberson PK, Manolagas SC. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology. 2010;151:2641–2649.
42. Yao W, Cheng Z, Koester KJ, Ager JW, Balooch M, Pham A, Chefo S, Busse C, Ritchie RO, Lane NE. The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength. Bone. 2007;41:804–812.
43. Yao W, Cheng Z, Pham A, Busse C, Zimmermann EA, Ritchie RO, Lane NE. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum. 2008;58:3485–3497.
44. Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res. 2010;25:190–199.
45. Yao W, Dai W, Shahnazari M, Pham A, Chen Z, Chen H, Guan M, Lane NE. Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice. PloS One. 2010;5:e11410.
46. Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE. Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells. 2013;31:2003–2014.